|
Post by sweedee79 on Jan 31, 2019 15:55:12 GMT -5
I'm getting the impression that someone who knows and understands the value of Afrezza has approached mannkind and even made offers regarding taking control of Afrezza in return for royalties..
That to me would be a great disappointment for shareholders
It would have to be some pretty darn good royalties to satisfy me after everything we have been through
Is there anything in our pipeline that has the potential Afrezza has had?
|
|
|
Post by #NoMoreNeedles on Jan 31, 2019 16:00:03 GMT -5
Most probably Bausch offering $500M max
|
|
|
Post by longtimerhere on Jan 31, 2019 16:01:10 GMT -5
Sweedee -- potential is a French word that means it hasn't done squat
|
|
|
Post by tingtongtung on Jan 31, 2019 16:20:15 GMT -5
Most probably Bausch offering $500M max You mean BHC? But,that's way out of what they do - isn't it?
|
|
|
Post by mytakeonit on Jan 31, 2019 16:44:19 GMT -5
Then maybe Lomb will do it? I think they are talking Bausch Health ...
|
|
|
Post by travis1953 on Jan 31, 2019 17:47:38 GMT -5
“We have been working diligently with our partner in Brazil and regulatory authorities to secure our first approval outside the U.S. and hope to have an update for you on this surely as the holidays slowed down our review unfortunately. We need to finish our part one of our pediatric program to file what is known as a PIP in the EU before we can engage in a meaningful filing application for Europe. We anticipate filing in Canada in the first half of 2019 and meeting with the European regulatory authorities to start a [indiscernible] over there as these are the two most common places where we get requests for Afrezza from our international inquiries.We know it takes time to gain regulatory approval in these markets and we’ll make appropriate call to look for one go-to-partner ex-U.S. or continue to find key partners in each market like we did with Brazil and India.” Where do Brazil and India currently stand in terms of progress towards selling afrezza.
|
|
|
Post by mango on Jan 31, 2019 18:15:40 GMT -5
I don't understand the logic behind selling off Afrezza before the completion of the pediatric clinic trial and the two other ongoing clinical trials—all of these are estimated to be completed in the near future.
There's no point in stressing over the things you can't control. Surrender to the flow. 😎
|
|
|
Post by morfu on Jan 31, 2019 18:25:30 GMT -5
Thanks Sports for saying 4-5 months. Enough. This cash drain from Afrezza has gone on too long. And for all you peeps saying give it the remainder of year, well that means coffers empty by December and another equity (stock) sale with us getting crushed again. You are right, and I believe that’s why Nate said do or die, you can’t keep issuing warrants and diluting the stock, you’ll have the stock below a dollar again it won’t work. We have a limited resources that’s not going to change so they will know in a few months whether this new campaign is going to work or not. They know the numbers they have to see, and hopefully so do potential partners. So this is the big push, ramp it up, make it work, or let it go. ( for a royalty ) Hmm quite a few posters here seem to badmouth the success of the last two years.. !? The scripts and sales doubled each year! Another year like this and we are very close to green with the USA Afrezza market alone.. Giving the other revenues we will finish this year green most likely! This is amazing stuff! No need for anything drastic at all! In fact the 20% Christmas dilution was a mistake, there is no need to change the current path to success!
|
|
|
Post by falconquest on Jan 31, 2019 18:42:45 GMT -5
IMO, once we see the elusive hockey stick within a few months, a BP U.S. sales partner will be announced with decent terms. The pps will move up nicely on the partnership announcement.Oh god please! That's the exact statement that got me into this stock at $19.00!
|
|
|
Post by sayhey24 on Jan 31, 2019 18:53:22 GMT -5
The 4Q2018 earnings call should be coming up in a week or two. Lets hope Mike has closed some of the international deals before the call.
In the U.S. until the SOC has significant updates especially in the T2 section I would not be expecting the hockey stick but rather slow and steady growth.
|
|
|
Post by mango on Jan 31, 2019 20:46:23 GMT -5
The 4Q2018 earnings call should be coming up in a week or two. Lets hope Mike has closed some of the international deals before the call. In the U.S. until the SOC has significant updates especially in the T2 section I would not be expecting the hockey stick but rather slow and steady growth. I believe that the SoC for T2D is criminal and needs to be completely eradicated in all of its forms. ADA walks and talks like a slush fund, and really needs a total dismantling from their sovereign-like position of authority and influence. Slow and steady growth for now, but eventually there is going to be a tipping point that is not dependent on the SoC.
|
|
|
Post by goyocafe on Jan 31, 2019 20:50:00 GMT -5
The 4Q2018 earnings call should be coming up in a week or two. Lets hope Mike has closed some of the international deals before the call. In the U.S. until the SOC has significant updates especially in the T2 section I would not be expecting the hockey stick but rather slow and steady growth. I believe that the SoC for T2D is criminal and needs to be completely eradicated in all of its forms. ADA walks and talks like a slush fund, and really needs a total dismantling from their sovereign-like position of authority and influence. Slow and steady growth for now, but eventually there is going to be a tipping point that is not dependent on the SoC. Start our own. Afrezza Diabetes Association. Nuff said.
|
|
|
Post by rockstarrick on Jan 31, 2019 21:19:20 GMT -5
I'm getting the impression that someone who knows and understands the value of Afrezza has approached mannkind and even made offers regarding taking control of Afrezza in return for royalties.. That to me would be a great disappointment for shareholders It would have to be some pretty darn good royalties to satisfy me after everything we have been through Is there anything in our pipeline that has the potential Afrezza has had? Exactly !! Everybody who is anybody at MNKD and even beyond, know exactly what Afrezza is !! They’re not going to sell it based on the next 6 months scripts, not cheap anyway. Interesting thread, and concept. I’d agree if it were any drug other than Afrezza, Al Mann’s greatest accomplishment. youtu.be/GoPpCWWyh-8Aint happening IMO ✌🏻😎
|
|